🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary goal of this study is to evaluate the safety and reactogenicity...
Status
Completed
Location
Accel Research Sites
Start Date
2022-10-14
Trial ID
NCT05585632
Treatments Being Tested
The study is divided into 2 parts (Part A and Part B). Part A of the study ...
Status
Completed
Location
Lenzmeier Family Medicine - CCT - PPDS
Start Date
2023-10-06
Trial ID
NCT06067230
Treatments Being Tested
The main objective of this trial is to evaluate the safety, reactogenicity,...
Status
Recruiting
Location
Diex Recherche Quebec
Start Date
2026-08-11
Trial ID
NCT07764237
Treatments Being Tested
Among non-pregnant adults observed in Epic Cosmos since August 2023 who are...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2026-06-22
Trial ID
NCT07673081
The purpose of this study is to evaluate safety, tolerability and immunogen...
Status
Completed
Location
Velocity Clinical Research, Denver
Start Date
2025-08-05
Trial ID
NCT07117487
Treatments Being Tested
The purpose of the study is to evaluate the reactogenicity, safety, and imm...
Status
Completed
Location
SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS
Start Date
2023-11-15
Trial ID
NCT06143046
The main goal of this study is to evaluate the safety, reactogenicity, and ...
Status
Completed
Location
CenExel
Start Date
2022-05-24
Trial ID
NCT05397223
The primary objectives of this study are to evaluate the tolerability and r...
Status
Completed
Location
Paradigm Clinical Research Institute Inc - ClinEdge - PPDS
Start Date
2020-09-30
Trial ID
NCT04528719
The main purpose of this study is to evaluate the safety and immunogenicity...
Status
Completed
Location
Scottsdale Clinical Trials
Start Date
2023-09-25
Trial ID
NCT06060457
Treatments Being Tested
The main purposes of Part A of this study are to evaluate the safety, toler...
Status
Completed
Location
Central Research Associates Inc
Start Date
2022-04-01
Trial ID
NCT05330975
Treatments Being Tested